Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Karpova D, Rettig MP, Ritchey J, Cancilla D, Christ S, Gehrs L, Chendamarai E, Evbuomwan MO, Holt M, Zhang J, Abou-Ezzi G, Celik H, Wiercinska E, Yang W, Gao F, Eissenberg LG, Heier RF, Arnett SD, Meyers MJ, Prinsen MJ, Griggs DW, Trumpp A, Ruminski PG, Morrow DM, Bonig HB, Link DC, DiPersio JF.

J Clin Invest. 2019 May 14;130:2745-2759. doi: 10.1172/JCI124738.

2.

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.

Hoggatt J, Singh P, Tate TA, Chou BK, Datari SR, Fukuda S, Liu L, Kharchenko PV, Schajnovitz A, Baryawno N, Mercier FE, Boyer J, Gardner J, Morrow DM, Scadden DT, Pelus LM.

Cell. 2018 Jan 11;172(1-2):191-204.e10. doi: 10.1016/j.cell.2017.11.003. Epub 2017 Dec 7.

3.

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury.

Entezari M, Javdan M, Antoine DJ, Morrow DM, Sitapara RA, Patel V, Wang M, Sharma L, Gorasiya S, Zur M, Wu W, Li J, Yang H, Ashby CR, Thomas D, Wang H, Mantell LL.

Redox Biol. 2014 Jan 20;2:314-22. doi: 10.1016/j.redox.2014.01.013. eCollection 2014.

4.

The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore.

Washburn DG, Holt DA, Dodson J, McAtee JJ, Terrell LR, Barton L, Manns S, Waszkiewicz A, Pritchard C, Gillie DJ, Morrow DM, Davenport EA, Lozinskaya IM, Guss J, Basilla JB, Negron LK, Klein M, Willette RN, Fries RE, Jensen TC, Xu X, Schnackenberg CG, Marino JP Jr.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4979-84. doi: 10.1016/j.bmcl.2013.06.047. Epub 2013 Jun 26.

PMID:
23886683
6.

Isolated neck-lifting procedure: isolated stork lift.

Barbarino SC, Wu AY, Morrow DM.

Aesthetic Plast Surg. 2013 Apr;37(2):205-9. doi: 10.1007/s00266-012-0002-3. Epub 2013 Jan 10.

PMID:
23307054
7.

The post-adjustable gastric band abdominoplasty.

Wu AY, Coon JL, Huerta S, Condé-Green A, Morrow DM.

Aesthet Surg J. 2012 Jul;32(5):634-46. doi: 10.1177/1090820X12450876.

PMID:
22745453
8.

Clinical use of Dieletrophoresis separation for live Adipose derived stem cells.

Wu AY, Morrow DM.

J Transl Med. 2012 May 17;10:99. doi: 10.1186/1479-5876-10-99. Erratum in: J Transl Med. 2014;12:270. Morrow, David M [removed].

9.

3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists.

Li YH, Tseng PS, Evans KA, Jaworski JP, Morrow DM, Fries HE, Wu CW, Edwards RM, Jin J.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6744-7. doi: 10.1016/j.bmcl.2010.08.137.

PMID:
20926294
10.

Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.

Thalji RK, Aiyar N, Davenport EA, Erhardt JA, Kallal LA, Morrow DM, Senadhi S, Burns-Kurtis CL, Marino JP Jr.

Bioorg Med Chem Lett. 2010 Jul 15;20(14):4104-7. doi: 10.1016/j.bmcl.2010.05.072. Epub 2010 Jun 9.

PMID:
20542694
11.

Small incision preperiosteal midface lift for correction of lower eyelid retraction.

Marshak H, Morrow DM, Dresner SC.

Ophthalmic Plast Reconstr Surg. 2010 May-Jun;26(3):176-81. doi: 10.1097/IOP.0b013e3181b8c00a.

PMID:
20489542
12.

Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat.

Jugus MJ, Jaworski JP, Patra PB, Jin J, Morrow DM, Laping NJ, Edwards RM, Thorneloe KS.

Br J Pharmacol. 2009 Sep;158(1):372-81. doi: 10.1111/j.1476-5381.2009.00275.x. Epub 2009 May 22.

13.

M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.

Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J.

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1686-90. doi: 10.1016/j.bmcl.2009.01.098. Epub 2009 Feb 4.

PMID:
19243945
14.

Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.

Morales-Ramos AI, Mecom JS, Kiesow TJ, Graybill TL, Brown GD, Aiyar NV, Davenport EA, Kallal LA, Knapp-Reed BA, Li P, Londregan AT, Morrow DM, Senadhi S, Thalji RK, Zhao S, Burns-Kurtis CL, Marino JP Jr.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6222-6. doi: 10.1016/j.bmcl.2008.09.102. Epub 2008 Oct 2.

PMID:
18926700
15.

Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.

Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5481-6. doi: 10.1016/j.bmcl.2008.09.020. Epub 2008 Sep 10.

PMID:
18818072
16.

Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.

Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI.

J Med Chem. 2008 Oct 9;51(19):5915-8. doi: 10.1021/jm800935u. Epub 2008 Sep 18.

PMID:
18798607
17.

"The stork lift": a circumoccipital extended neck-lift.

Marshak H, Morrow DM.

Aesthetic Plast Surg. 2008 Nov;32(6):850-5; discussion 856-7. doi: 10.1007/s00266-008-9236-5. Epub 2008 Aug 28.

PMID:
18752019
18.

Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.

Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J.

J Med Chem. 2008 Aug 28;51(16):4866-9. doi: 10.1021/jm800634k. Epub 2008 Aug 5.

PMID:
18680280
19.

Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system.

Su X, Leon LA, Wu CW, Morrow DM, Jaworski JP, Hieble JP, Lashinger ES, Jin J, Edwards RM, Laping NJ.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F984-94. doi: 10.1152/ajprenal.90373.2008. Epub 2008 Jul 16.

20.

Biplanar temple lift for lateral brow ptosis: comparison with uniplanar dissection technique.

Marshak H, Morrow AA, Morrow DM.

Aesthetic Plast Surg. 2008 May;32(3):517-22. doi: 10.1007/s00266-008-9131-0. Epub 2008 Mar 11.

PMID:
18330618
21.

Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia.

Morrow DM, Entezari-Zaher T, Romashko J 3rd, Azghani AO, Javdan M, Ulloa L, Miller EJ, Mantell LL.

Free Radic Biol Med. 2007 May 1;42(9):1338-49. Epub 2007 Jan 23.

22.

Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells.

Zaher TE, Miller EJ, Morrow DM, Javdan M, Mantell LL.

Free Radic Biol Med. 2007 Apr 1;42(7):897-908. Epub 2007 Jan 17. Review.

23.

Oxazolidinones as novel human CCR8 antagonists.

Jin J, Wang Y, Wang F, Kerns JK, Vinader VM, Hancock AP, Lindon MJ, Stevenson GI, Morrow DM, Rao P, Nguyen C, Barrett VJ, Browning C, Hartmann G, Andrew DP, Sarau HM, Foley JJ, Jurewicz AJ, Fornwald JA, Harker AJ, Moore ML, Rivero RA, Belmonte KE, Connor HE.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1722-5. Epub 2006 Dec 24.

PMID:
17267215
24.

NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis.

Franek WR, Morrow DM, Zhu H, Vancurova I, Miskolci V, Darley-Usmar K, Simms HH, Mantell LL.

Free Radic Biol Med. 2004 Nov 15;37(10):1670-9.

PMID:
15477018
25.

Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation.

Morrow DM, Fitzsimmons PE, Chopra M, McGlynn H.

Mutat Res. 2001 Sep 1;480-481:269-76.

PMID:
11506819
26.

Antioxidant prevention of tumour promoter induced inhibition of intercellular communication in renal cell lines.

Morrow DM, McGlynn H.

Biochem Soc Trans. 1997 Nov;25(4):S561. No abstract available.

PMID:
9449989
27.
28.

Downregulation of intracellular cyclic AMP levels by tumour promoting agents.

Morrow DM, Ryan MP, McGlynn H.

Biochem Soc Trans. 1997 Feb;25(1):148S. No abstract available.

PMID:
9057046
29.

The ATM homologue MEC1 is required for phosphorylation of replication protein A in yeast.

Brush GS, Morrow DM, Hieter P, Kelly TJ.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15075-80.

30.

Exploiting the complete yeast genome sequence.

Bassett DE Jr, Basrai MA, Connelly C, Hyland KM, Kitagawa K, Mayer ML, Morrow DM, Page AM, Resto VA, Skibbens RV, Hieter P.

Curr Opin Genet Dev. 1996 Dec;6(6):763-6. Review.

PMID:
8994849
31.

Platelet immunoregulatory factors.

Tykocinski ML, Xiong N, Morrow DM.

Stem Cells. 1996;14 Suppl 1:240-5. Review.

32.
33.

Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage.

Morrow DM, Xiong N, Getty RR, Ratajczak MZ, Morgan D, Seppala M, Riittinen L, Gewirtz AM, Tykocinski ML.

Am J Pathol. 1994 Dec;145(6):1485-95.

34.

Re: Carbon dioxide laser blepharoplasty--advantages and disadvantages.

Morrow DM.

Ann Plast Surg. 1992 Apr;28(4):397-9. No abstract available.

PMID:
1596080
35.

CO2 laser blepharoplasty.

Morrow DM.

J Dermatol Surg Oncol. 1992 Apr;18(4):340. No abstract available.

PMID:
1560161
36.

CO2 laser blepharoplasty. A comparison with cold-steel surgery.

Morrow DM, Morrow LB.

J Dermatol Surg Oncol. 1992 Apr;18(4):307-13.

PMID:
1560155
37.

Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.

Hocevar BA, Morrow DM, Tykocinski ML, Fields AP.

J Cell Sci. 1992 Mar;101 ( Pt 3):671-9.

38.

Chemical peeling of eyelids and periorbital area.

Morrow DM.

J Dermatol Surg Oncol. 1992 Feb;18(2):102-10.

PMID:
1537947
39.

Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors.

Groger RK, Morrow DM, Tykocinski ML.

Gene. 1989 Sep 30;81(2):285-94. Erratum in: Gene 1989 Nov 30;83(2):395.

PMID:
2478421
40.

Vermilionectomy for squamous-cell carcinoma.

Morrow DM.

J Dermatol Surg Oncol. 1983 Feb;9(2):104-5. No abstract available.

PMID:
6833604
41.

Hypersensitivity to aloe.

Morrow DM, Rapaport MJ, Strick RA.

Arch Dermatol. 1980 Sep;116(9):1064-5.

PMID:
7416761

Supplemental Content

Loading ...
Support Center